Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Integrated Prevention, Treatment, and Rehabilitation for Toileting-Related Falls

27 de julio de 2026 actualizado por: Qing Yuan

Construction, Validation, and Demonstration of a Comprehensive Prevention, Treatment, and Rehabilitation System for Toileting-Related Falls in Older Adults and People With Disabilities

Toileting-related falls may result from a combination of urinary symptoms, impaired gait and balance, reduced muscle strength, cognitive or emotional problems, and unsafe environmental conditions. Older adults and people with disabilities may be especially vulnerable because they frequently require assistance or must move quickly, particularly during nighttime toileting.

This multicenter prospective study will evaluate a comprehensive prevention, treatment, and rehabilitation program for older adults and people with disabilities who are at risk of toileting-related falls. Participants will receive a standardized multidimensional assessment covering urinary function, gait and balance, physical function, psychological and cognitive factors, activities of daily living, previous falls, and environmental risks.

Based on the risks identified, each participant will receive an individualized combination of interventions. These may include urinary symptom management, gait and balance rehabilitation, strength and mobility training, psychological or cognitive support, caregiver education, and modification of the toileting environment. Participants will be followed and reassessed, and their management plans may be adjusted according to changes in risk and clinical condition.

The study will evaluate the feasibility, implementation, and safety of this integrated care program, as well as changes in toileting-related falls, nighttime falls, urinary symptoms, mobility and balance, activities of daily living, and fear of falling.

Descripción general del estudio

Descripción detallada

Toileting-related falls are clinically important events that may occur through the interaction of urinary urgency, nocturia, urinary incontinence, impaired mobility, gait and balance dysfunction, reduced muscle strength, cognitive or psychological problems, inadequate caregiver support, and environmental hazards. Conventional fall-prevention programs often focus mainly on mobility or environmental risks, whereas urinary symptoms and toileting-related exposure may not be addressed within the same care pathway.

This study is a multicenter, prospective, single-group interventional study designed to construct, validate, and demonstrate a comprehensive prevention, treatment, and rehabilitation system for toileting-related falls in older adults and people with disabilities. The study integrates urological care, rehabilitation, nursing, psychological support, caregiver involvement, environmental risk management, and longitudinal follow-up within a standardized dynamic management pathway.

The study pathway consists of the following stages:

  1. Participant screening and enrollment;
  2. Standardized multidimensional baseline assessment;
  3. Identification and stratification of modifiable risk factors;
  4. Development and delivery of an individualized multicomponent intervention plan;
  5. Follow-up and repeat assessment;
  6. Adjustment of the intervention plan based on clinical response, adherence, safety, and changes in risk;
  7. Feedback and continuous improvement of the implementation process.

The multidimensional assessment will cover the following major domains:

Urinary function: urinary frequency, urgency, nocturia, urinary incontinence, voiding difficulty, bladder-related symptoms, voiding diaries, and other clinically indicated urinary function measurements.

Gait, balance, and physical function: muscle strength, muscle tone, joint mobility, transfer ability, sit-to-stand performance, gait, balance, use of mobility aids, and fall risk.

Psychological and cognitive factors: fear of falling, anxiety, depressive symptoms, fall-related psychological responses, cognition, treatment cooperation, and caregiver support.

Activities of daily living and environmental risks: independence in toileting and other daily activities, nighttime lighting, the route from the bed to the toilet, slippery surfaces, handrails, toilet height, thresholds, availability of assistive devices, and caregiver response.

Interventions will be individualized according to the participant's predominant and modifiable risk factors. The intervention package may include behavioral and clinical management of urinary symptoms, bladder training, medication optimization when clinically appropriate, neuromodulation or electrical stimulation when indicated, gait and balance rehabilitation, muscle-strengthening and mobility training, transfer training, assistive-device adaptation, psychological or cognitive support, caregiver education, scheduled or assisted toileting, and modification of environmental hazards.

Not every participant will receive every intervention. The specific intervention combination will be selected according to the standardized assessment, clinical indications, participant needs, safety considerations, and available resources at each participating center.

Participants will undergo longitudinal follow-up to document intervention delivery, adherence, adverse events, repeat assessments, falls, toileting-related falls, nighttime falls, urinary symptoms, physical function, activities of daily living, and fear of falling. Intervention plans may be modified during follow-up when clinically indicated.

The study will assess both implementation outcomes and clinical outcomes. Implementation evaluation will include participant reach, institutional adoption, completion of standardized assessments, delivery of individualized interventions, protocol adherence, staff training, data completeness, follow-up completion, safety, and sustainability of the care pathway. Clinical evaluation will examine changes in toileting-related falls and related risk factors, including urinary symptoms, nocturia, gait and balance, functional independence, and fear of falling.

The overall aim is to determine whether this integrated and dynamically adjusted care pathway can be implemented safely and consistently across different clinical and rehabilitation settings and provide a reproducible model for the prevention and management of toileting-related falls.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

300

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Qing Yuan, MD, PhD
  • Número de teléfono: +8618910980422
  • Correo electrónico: qyuanmd@outlook.com

Ubicaciones de estudio

    • Beijing Municipality
      • Beijing, Beijing Municipality, Porcelana, 100039
        • Chinese PLA General Hospital
        • Contacto:
          • Qing Yuan, MD, PhD
          • Número de teléfono: +8618910980422

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

No

Descripción

Inclusion Criteria:

  • Age 18 years or older, with no upper age limit.
  • Presence of physical disability, functional limitation, loss of independence, or a need for assistance with daily activities.
  • Presence of at least one risk factor for toileting-related falls, including but not limited to urinary frequency, urinary urgency, nocturia, urinary incontinence, voiding difficulty, overactive bladder, underactive bladder, impaired gait or balance, reduced muscle strength, fear of falling, cognitive or emotional problems, a history of falls, unsafe nighttime toileting, or environmental hazards associated with toileting.
  • Able and willing to participate in the study assessments and follow-up procedures, with assistance from a caregiver when necessary.
  • Written informed consent provided by the participant or, when applicable, by a legally authorized representative.

Exclusion Criteria:

  • Acute infection or other acute medical condition requiring immediate treatment that would prevent participation in study assessments or interventions.
  • Severe or unstable medical condition that, in the investigator's judgment, would make participation unsafe or interfere with study procedures or follow-up.
  • Severe disturbance of consciousness or other condition that prevents completion of the required assessments and study procedures, even with appropriate assistance.
  • Inability to participate in the planned follow-up or provide sufficient study-related information.
  • Any other condition that, in the investigator's judgment, makes the individual unsuitable for participation in the study.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Prevención
  • Asignación: N / A
  • Modelo Intervencionista: Asignación de un solo grupo
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Integrated Multidimensional Management Program
Participants will receive a comprehensive, individualized, multidimensional management program for the prevention of toileting-related falls. Following standardized assessment of urinary function, gait and balance, physical function, psychological and cognitive factors, activities of daily living, and environmental risks, participants will receive a tailored combination of interventions according to their identified risk factors and clinical indications. Interventions may include urinary symptom management, bladder training, medication optimization, neuromodulation or electrical stimulation when indicated, gait and balance rehabilitation, strength and mobility training, psychological or cognitive support, caregiver education, assisted or scheduled toileting, and environmental modification. Intervention plans may be adjusted during follow-up based on reassessment, clinical response, adherence, and safety.

Participants will receive an individualized, multicomponent management program based on standardized multidimensional assessment and risk stratification. The assessment covers urinary function, gait and balance, physical function, psychological and cognitive factors, activities of daily living, caregiver support, and environmental risks related to toileting.

The intervention plan will be tailored to each participant's identified modifiable risk factors and clinical indications. Components may include management of urinary symptoms and nocturia, bladder and behavioral training, clinically indicated treatment optimization, neuromodulation or electrical stimulation when appropriate, gait and balance rehabilitation, muscle-strengthening and mobility training, assistive-device adaptation, psychological or cognitive support, caregiver education, scheduled or assisted toileting, and environmental modification.

Not all participants will receive every component. Intervention plans may be adju

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Proportion of Participants Experiencing at Least One Toileting-Related Fall During Follow-up
Periodo de tiempo: 6 months
The proportion of participants who experience at least one toileting-related fall during the follow-up period. A toileting-related fall is defined as a fall occurring in association with going to the toilet, using the toilet, transferring on or off the toilet, or returning from the toilet. The proportion will be calculated as the number of participants with at least one toileting-related fall divided by the total number of participants included in the follow-up analysis.
6 months

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Number of Nighttime Toileting-Related Falls During the 6-Month Follow-up
Periodo de tiempo: 6 months
The total number of nighttime toileting-related falls experienced by each participant during the 6-month follow-up period. A nighttime toileting-related fall is defined as a fall occurring during nighttime in association with going to the toilet, using the toilet, transferring on or off the toilet, or returning from the toilet.
6 months
Total Number of Falls During the 6-Month Follow-up
Periodo de tiempo: 6 months
The total number of falls experienced by each participant during the 6-month follow-up period, regardless of whether the fall is related to toileting.
6 months
Change in Overactive Bladder Symptom Score From Baseline to 6 Months
Periodo de tiempo: Baseline and 6 months
Change in the Overactive Bladder Symptom Score (OABSS) from baseline to 6 months. The OABSS evaluates daytime urinary frequency, nocturia, urinary urgency, and urgency urinary incontinence. Total scores range from 0 to 15, with higher scores indicating more severe overactive bladder symptoms.
Baseline and 6 months
Change in Average Number of Nocturia Episodes per Night From Baseline to 6 Months
Periodo de tiempo: Baseline and 6 months
Change in the average number of nocturnal voiding episodes per night from baseline to 6 months, assessed using participant-reported voiding records or voiding diaries. Nocturia is defined as waking from sleep to void during the nighttime period.
Baseline and 6 months
Change in Tinetti Performance-Oriented Mobility Assessment Score From Baseline to 6 Months
Periodo de tiempo: Baseline and 6 months
Change in the total Tinetti Performance-Oriented Mobility Assessment score from baseline to 6 months. The assessment evaluates balance and gait performance. Higher scores indicate better mobility and a lower risk of falls.
Baseline and 6 months
Change in Modified Barthel Index From Baseline to 6 Months
Periodo de tiempo: Baseline and 6 months
Change in the Modified Barthel Index from baseline to 6 months. The index assesses independence in activities of daily living, including personal care, toileting, mobility, transfers, and other daily activities. Higher scores indicate greater functional independence.
Baseline and 6 months
Completion Rate of the Multidimensional Baseline Assessment
Periodo de tiempo: At baseline
The proportion of enrolled participants who complete all protocol-required and applicable baseline assessment domains, including urinary function, gait and balance, physical function, psychological and cognitive factors, activities of daily living, fall history, and toileting-related environmental risks.
At baseline

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
Enrollment Rate Among Eligible Screened Individuals
Periodo de tiempo: At completion of recruitment, up to 12 months after recruitment initiation
The proportion of eligible screened individuals who are enrolled in the study. The enrollment rate will be calculated as the number of participants enrolled divided by the total number of screened individuals who meet the study eligibility criteria, multiplied by 100.
At completion of recruitment, up to 12 months after recruitment initiation
Proportion of Participants Receiving a Risk-Based Individualized Intervention
Periodo de tiempo: Up to 6 months after enrollment
The proportion of enrolled participants who, after multidimensional assessment and risk stratification, receive at least one documented individualized intervention matched to their identified risk factors and clinical indications.
Up to 6 months after enrollment
Six-Month Follow-up Completion Rate
Periodo de tiempo: At 6 months
The proportion of enrolled participants who complete the planned 6-month follow-up assessment. Completion requires documentation of the participant's follow-up status and collection of the core follow-up outcome data specified in the study protocol.
At 6 months
Completeness of Required Study Data
Periodo de tiempo: Up to 6 months after enrollment
The percentage of protocol-required data fields that are completed among all required data fields for enrolled participants. Data completeness will be assessed for baseline assessments, intervention records, follow-up records, and predefined study outcomes.
Up to 6 months after enrollment

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Publicaciones Generales

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de agosto de 2026

Finalización primaria (Estimado)

1 de agosto de 2028

Finalización del estudio (Estimado)

1 de diciembre de 2028

Fechas de registro del estudio

Enviado por primera vez

22 de julio de 2026

Primero enviado que cumplió con los criterios de control de calidad

27 de julio de 2026

Publicado por primera vez (Actual)

31 de julio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

31 de julio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

27 de julio de 2026

Última verificación

1 de julio de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • PLAGH-TOILETFALL-2023-750

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir